Answer
Combining trastuzumab with doxorubicin hydrochloride increases cardiotoxic risk, and they should not be used together except in well-controlled clinical studies with cardiac function monitoring.
Sources for this answer
- Doxorubicin Solution for InjectionPfizer Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 12Document updated
Sources checked